Evidence map›Paper›PMID 31407824›Full record

ReviewJournal of clinical pharmacy and therapeutics2019

Topical (local) antibiotics for respiratory infections with sore throat: An antibiotic stewardship perspective.

Sabiha Essack, John Bell, Douglas S Burgoyne, Martin Duerden, Adrian Shephard

Open access · hybridAbstract readReview
In one paragraph

Review in Journal of clinical pharmacy and therapeutics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Over-the-counter antibiotics compromising aminoglycoside activity.The Journal of antimicrobial chemotherapy · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. The microbiome-shaping roles of bacteriocins.Nature reviews. Microbiology · 2021
    Review
  8. Review
  9. Peaks in online inquiries into pharyngitis-related symptoms correspond with annual incidence rates.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2021
    Article
  10. Article
  11. Review
  12. Frontiers in microbiology · 2021
    Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 4 countries.

Sabiha EssackAntimicrobial Research Unit, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
John BellGraduate School of Health, University of Technology, Sydney, NSW, Australia.
Douglas S BurgoyneCooperative Benefits Group, Salt Lake City, UT, USA.
Martin DuerdenSchool of Medicine, Centre for Medical Education, Cardiff University, Cardiff, UK.
Adrian ShephardReckitt Benckiser Healthcare Ltd UK, Slough, UK.ORCID https://orcid.org/0000-0002-4020-1486
Cardiff University · GBEastern Cooperative Oncology Group · USReckitt Benckiser (United Kingdom) · GBUniversity of KwaZulu-Natal · ZAUniversity of Technology Sydney · AU

Funding

Reckitt Benckiser Healthcare Ltd, UK
6 · The paper itself

Abstract

WHAT IS KNOWN AND

objectiveThe overuse and misuse of antibiotics, especially for viral, and self-limiting, respiratory tract infections such as sore throat, increases the risk of the development and spread of antimicrobial resistance within communities. Up to 80% of sore throat cases have a viral aetiology, and even when the infection is bacterial, most cases resolve without antibiotics. However, antibiotics are still frequently and often inappropriately prescribed for the treatment of sore throat. Furthermore, topical (local) antibiotics for treatment of sore throat are widely available over the counter. The objective of this systematic review was to establish the evidence for the benefits, risk of harm and antimicrobial resistance associated with topical (local) antibiotics used for patients with sore throat.

methodsEligible studies included those in patients with sore throat of any aetiology receiving the topical (local) antibiotics tyrothricin, bacitracin, gramicidin or neomycin where the antibiotic was topically/locally applied via the nasal cavity or throat. Nasal applications were included as these are occasionally used to treat upper respiratory tract infections that may involve sore throat. There was no restriction or requirement regarding comparator. The outcomes of interest included efficacy, safety, and in vitro culture and antimicrobial resistance data. RESULTS AND DISCUSSION: This systematic review found sparse and mainly poor-quality evidence relating to the use of topical (local) antibiotics for sore throat, and it was not possible to establish the benefits, risk of harm or impact of use on antimicrobial resistance. WHAT IS NEW AND

conclusionsFurther research is necessary to ascertain the risks and benefits of topical (local) antibiotics, their contribution to antimicrobial resistance and the risk of harm. We do, however, question whether it is appropriate and rational to use topical (local) antibiotics for the treatment of sore throat caused by respiratory tract infections in the absence of robust evidence.

Indexed as

Administration, TopicalAnti-Bacterial AgentsAntimicrobial StewardshipHumansPharyngitisRespiratory Tract InfectionsAnti-Bacterial Agentsantimicrobial resistancebenefitsrespiratory tract infectionsrisk of harmsore throattopical (local) antibiotics

Identifiers

PMID31407824
PMCPMC6899613
OpenAlexW2968757452

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.